Day 1 - Friday, 8 June 2018
Meeting category
Date(s)
8 Jun 2018 - 9 Jun 2018
Location
Madrid,
Spain
Organizer
Spanish HIV Clinical Forum 2018
Related Enduring Materials
Enduring Materials
Session 1: State of the Art Update - Integrase Inhibitors -
State of the ART: Integrase Inhibitors Clinical Data
State of the ART: Integrase Inhibitors Resistance (an update) (Not available)
Abstract driven presentations
Integrase inhibitors and virological failure: a cohort analysis (Not available)
Montejano, Rocio. Hospital Universitario La Paz, Madrid
Análisis descriptivo de mutaciones asociadas a resistencia (MR) para inhibidores de la integrasa (INI) del VIH en el Hospital Universitario de La Princesa de Madrid (Not available)
García-Fraile Fraile, Lucio Jesús. Hospital Universitario De La Princesa, Madrid
Session 2: Changing the paradigm: Reduced drug regimens -
Josep Llibre, MD, PhD
What is the Virological support for reduced drug regimens?
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
What is the Pharmacological support for reduced drug regimens?
What are the Clinical data for reduced drug regimens?
Babafemi O. Taiwo, MBBS
Northwestern University, USA
Abstract-driven presentations
Comparative clinical experience with the two STR co-formulations with integrase inhibitors for the treatment of HIV patients (Not available)
Hernández García, Guiomar. Hospital Universitario Príncipe De Asturias, Alcalá De Henares
Eficacia y tolerabilidad del tratamiento con Elvitegravir, Cobicistat, Emtricitabina y Tenofovir Alafenamida (EVG/COBI/FTC/TAF) en pacientes con infección por VIH. Análisis a 24 semanas (Not available)
Bautista, Azucena. Hospital De La Princesa, Madrid
Biterapias basadas en Dolutegravir: ¿son una realidad y una necesidad en la práctica clínica diaria? (Not available)
Ferrer, Ana. Hospital Clínico Universitario, Valencia
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study
Troya, Jésus. Hospital Universitario Infanta Leonor, Madrid
Day 2 - Saturday, 9 June 2019
Session 3: Integrase Inhibitors in Routine Care -
Optimizing Clinical Care
Optimal Clinical Care in special populations (Not yet available)
Matilde Sánchez Conde, MD
Hospital Universitario Ramón y Cajal, Madrid
Abstract driven presentation
Interstitial pneumonia by triple viral co-infection in a CDC C2 HIV- infected patient
Bracke, Carme. Hospital Germans Trias I Pujol, Badalona
Clinical Case presentation
Session 4: Novel delivery systems -
Integrating novel delivery systems/novel drugs
Overview
Welcome
We would like to thank you for joining us at the Spanish HIV Clinical Forum: Integrase Inhibitors 2018 in Madrid, Spain! With excellent discussions and lectures during this meeting, it was a great success! We hope you enjoyed it too.
On behalf of the Spanish HIV Clinical Forum Meeting Chairs, we would like to thank ViiV Healthcare for their unrestricted educational grant. We would also like to thank our endorsers for their invaluable support of the meeting and of course a big thank you to all of our participants in making this meeting into a huge success!
Background
The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.
Support
Support
